Open AccessGestational Trophoblastic Neoplasia Treatment at the Butaro Cancer Center of Excellence in Rwanda
Author(s) -
Ignace Nzayisenga,
Roanne Segal,
Natalie Pritchett,
Mary Jue Xu,
Paul H. Park,
Edgie V. Mpanumusingo,
Denis Gilbert Umuhizi,
Donald P. Goldstein,
Ross S. Berkowitz,
Vedaste Hategekimana,
Clemence Muhayimana,
Fidel Rubagumya,
Temidayo Fadelu,
Neo Tapela,
Tharcisse Mpunga,
Rahel Ghebre
Publication year - 2016
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.2015.002568
Subject(s) - medicine , dilation and curettage , methotrexate , gestational trophoblastic disease , etoposide , surgery , obstetrics , pregnancy , chemotherapy , gestation , abortion , genetics , biology
Gestational trophoblastic neoplasia (GTN) is a highly treatable disease, most often affecting young women of childbearing age. This study reviewed patients managed for GTN at the Butaro Cancer Center of Excellence (BCCOE) in Rwanda to determine initial program outcomes.